Ginkgo bioworks announces date of first quarter 2022 results presentation

Presentation and q&a session scheduled for post-market on monday, may 16, 2022 boston , may 9, 2022 /prnewswire/ -- ginkgo bioworks (nyse: dna), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and q&a session reviewing business performance for the first quarter ended march 31, 2022, on monday, may 16, 2022, beginning at 4:30 p.m. et. the presentation details and webcast link will be available on ginkgo's investor relations website at https://investors.ginkgobioworks.com , and a replay will be made available.
DNA Ratings Summary
DNA Quant Ranking